MLS1547
CAS No. 315698-36-3
MLS1547( MLS-1547 | MLS 1547 | MLS000051547 )
Catalog No. M27901 CAS No. 315698-36-3
MLS1547 is a highly efficacious agonist of G protein-biased dopamine D2 receptor with a Ki of 1.2 μM. MLS1547 stimulates D2R G protein-mediated signaling with EC50 of 0.37 μM in a calcium mobilization assay.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 39 | Get Quote |
|
10MG | 53 | Get Quote |
|
25MG | 79 | Get Quote |
|
50MG | 111 | Get Quote |
|
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMLS1547
-
NoteResearch use only, not for human use.
-
Brief DescriptionMLS1547 is a highly efficacious agonist of G protein-biased dopamine D2 receptor with a Ki of 1.2 μM. MLS1547 stimulates D2R G protein-mediated signaling with EC50 of 0.37 μM in a calcium mobilization assay.
-
DescriptionMLS1547 is a highly efficacious agonist of G protein-biased dopamine D2 receptor with a Ki of 1.2 μM. MLS1547 stimulates D2R G protein-mediated signaling with EC50 of 0.37 μM in a calcium mobilization assay.(In Vitro):MLS1547 fully antagonizes dopamine-mediated β-arrestin recruitment to the D2 dopamine receptor with an IC50 of 9.9 μM in the DiscoveRx assay and 3.8 μM in the BRET assay. MLS1547 is found to completely displace [3H]methylspiperone binding to the D2 dopamine receptor, with a calculated Ki of 1.2 μM.
-
In VitroMLS1547 fully antagonizes dopamine-mediated β-arrestin recruitment to the D2R in the DiscoveRx assay, with an IC50 of 9.9 μM. Similar results were obtained when MLS1547 was examined for antagonist activity in the D2R β-arrestin BRET assay, demonstrating an IC50 of 3.8 μM. MLS1547 is found to completely displace [3H]methylspiperone binding to the D2R, with a calculated Ki of 1.2 μM.
-
In Vivo——
-
SynonymsMLS-1547 | MLS 1547 | MLS000051547
-
PathwayGPCR/G Protein
-
TargetDopamine Receptor
-
RecptorSOD1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number315698-36-3
-
Formula Weight354.84
-
Molecular FormulaC19H19ClN4O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 33.33 mg/mL (93.93 mM)
-
SMILESOc1c(CN2CCN(CC2)c2ccccn2)cc(Cl)c2cccnc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Chisholm CL, et al. Ammonium tetrathiomolybdate treatment targets the copper transporter ATP7A and enhances sensitivity of breast cancer to cisplatin. Oncotarget. 2016 Oct 31.
molnova catalog
related products
-
FAUC-365
FAUC-365 is a D3 dopamine receptor agonist.
-
Trifluoperazine dihy...
An antiadrenergic, antidopaminergic and anticholinergic agent.
-
Bromocriptine mesyla...
Bromocriptine (CB-154) is a dopamine D2 receptor agonist (Ki=3 nM) and and various serotonin receptors, also inhibits the release of glutamate by reversing the glutamate GLT1 transporter.